Antifilarial activity of levamisole hydrochloride against subperiodic Brugia malayi infection of domestic cats.
D000818:Animals; D002415:Cats; D004804:Eosinophils; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005334:Fever / Q000139:chemically induced; D005368:Filariasis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005370:Filarioidea; D005921:Glomerulonephritis / Q000139:chemically induced; D006801:Humans; D007962:Leukocytes; D007978:Levamisole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008109:Liver Diseases, Parasitic / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009120:Muscle Cramp / Q000139:chemically induced; D010507:Periodicity; D011024:Pneumonia, Viral / Q000139:chemically induced; D011704:Pyelonephritis / Q000139:chemically induced; D012472:Salivation; D013154:Spleen
D007978:Levamisole